GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » Beneish M-Score

NIVF (NewGenIvf Group) Beneish M-Score : 0.00 (As of Mar. 19, 2025)


View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for NewGenIvf Group's Beneish M-Score or its related term are showing as below:

During the past 3 years, the highest Beneish M-Score of NewGenIvf Group was 0.00. The lowest was 0.00. And the median was 0.00.


NewGenIvf Group Beneish M-Score Historical Data

The historical data trend for NewGenIvf Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group Beneish M-Score Chart

NewGenIvf Group Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -

NewGenIvf Group Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score - - - - -

Competitive Comparison of NewGenIvf Group's Beneish M-Score

For the Medical Care Facilities subindustry, NewGenIvf Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NewGenIvf Group's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's Beneish M-Score falls into.



NewGenIvf Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of NewGenIvf Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $1.02 Mil.
Revenue was $5.14 Mil.
Gross Profit was $1.68 Mil.
Total Current Assets was $1.20 Mil.
Total Assets was $1.65 Mil.
Property, Plant and Equipment(Net PPE) was $0.45 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.23 Mil.
Selling, General, & Admin. Expense(SGA) was $1.64 Mil.
Total Current Liabilities was $1.12 Mil.
Long-Term Debt & Capital Lease Obligation was $0.12 Mil.
Net Income was $0.13 Mil.
Gross Profit was $0.11 Mil.
Cash Flow from Operations was $-1.77 Mil.
Total Receivables was $2.32 Mil.
Revenue was $5.94 Mil.
Gross Profit was $1.54 Mil.
Total Current Assets was $2.40 Mil.
Total Assets was $2.91 Mil.
Property, Plant and Equipment(Net PPE) was $0.51 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.30 Mil.
Selling, General, & Admin. Expense(SGA) was $1.14 Mil.
Total Current Liabilities was $2.56 Mil.
Long-Term Debt & Capital Lease Obligation was $0.25 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.021 / 5.136) / (2.324 / 5.944)
=0.198793 / 0.390983
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.538 / 5.944) / (1.682 / 5.136)
=0.258748 / 0.327492
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1.201 + 0.446) / 1.647) / (1 - (2.399 + 0.506) / 2.905)
=0 / -0
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5.136 / 5.944
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.304 / (0.304 + 0.506)) / (0.23 / (0.23 + 0.446))
=0.375309 / 0.340237
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.64 / 5.136) / (1.139 / 5.944)
=0.319315 / 0.191622
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.119 + 1.122) / 1.647) / ((0.249 + 2.556) / 2.905)
=0.753491 / 0.965577
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.13 - 0.112 - -1.766) / 1.647
=1.083182

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.


NewGenIvf Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


NewGenIvf Group Business Description

Traded in Other Exchanges
N/A
Address
Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.